Overview
Veracyte develops genomic diagnostic tests that help physicians make more accurate diagnoses and better-informed treatment decisions in thyroid cancer, lung cancer, and other difficult-to-diagnose conditions.
More in Clinical Diagnostics
Latest industry news
DNA Testing Technology Emerges as a New Frontier in Cold Case Investigations
2026-10-24 · Policy
Whole Genome Sequencing for the General Public: Is the Value Proposition Finally There?
2026-10-23 · Research
Mayo Clinic's Molecular Diagnostic Revolution: How Hussam Al Kateb Is Reshaping Clinical Genomics
2026-10-22 · Industry
Karolinska's Multi-Omics Push: Inside One of Europe's Most Ambitious Precision Medicine Programs
2026-10-21 · Research
Company details
Category
🏥 Clinical Diagnostics
Location
San Francisco, California, USA
Funding
Publicly traded on NASDAQ: VCYT; raised over $500 million through public offerings and partnerships
Website
www.veracyte.comListed
2026-07-20
Is this your company?
Claim this listing to add your logo, full description, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach genomics professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →